TILT Biotherapeutics Oy
TILT Biotherapeutics Oy is a Healthcare & Life Sciences startup based in All, most recent round Series B, 1 tracked investor.
About TILT Biotherapeutics Oy
TILT Biotherapeutics Oy is a startup founded in 2013 based in All. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
TILT Biotherapeutics is a clinical-stage biotechnology company developing next-generation oncolytic viral immunotherapies for solid tumors. Their lead investigational therapy, TILT-123 (igrelimogene litadenorepvec), is an intravenously delivered adenoviral therapy armed with TNF and IL-2 intended to stimulate anti-tumor T-cell responses.
Explore TILT Biotherapeutics Oy's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.